(Q42288534)

19 October 2017

title

Serum levels of tissue inhibitor of metalloproteinase-1 are correlated with liver fibrosis in patients with chronic hepatitis B. (English)

1 reference

19 October 2017

1 reference

Chuan Long Zhu

1

1 reference

19 October 2017

Wen Ting Li

series ordinal

2

1 reference

19 October 2017

Yi Li

series ordinal

3

1 reference

19 October 2017

Ren Tao Gao

series ordinal

4

1 reference

19 October 2017

publication date

1 November 2012

1 reference

Journal of Digestive Diseases

19 October 2017

published in

1 reference

19 October 2017

volume

13

1 reference

19 October 2017

issue

11

1 reference

19 October 2017

page(s)

558-563

1 reference

Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

Therapeutic targets in liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

Serum markers detect the presence of liver fibrosis: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

Liver fibrosis -- from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

TNF-alpha and IL-1beta-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

Degradation of matrix proteins in liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2012.00629.X

10.1111/J.1751-2980.2012.00629.X

21 January 2018

Identifiers

DOI

1 reference

19 October 2017

1 reference